ADANIENT vs SUNPHARMA: Stock Comparison
Sun Pharmaceutical Industries Ltd is the larger company by market capitalisation. Adani Enterprises Ltd shows faster revenue growth, while Sun Pharmaceutical Industries Ltd shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
ADANIENT leads 4; SUNPHARMA leads 9 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | ADANIENT | SUNPHARMA |
|---|---|---|
| Sector | Metals & Mining | Healthcare |
| Industry | Trading - Minerals | Pharmaceuticals |
Price
| Metric | ADANIENT | SUNPHARMA |
|---|---|---|
| Live Price | ₹2,985.7 | ₹1,944 |
| Day Change | -0.33% | 0.1% |
| Volume | 11.6 L | 15.36 L |
| 52-Week High | ₹3,245 | ₹2,046.9 |
| 52-Week Low | ₹1,753 | ₹1,548 |
| Distance from 52W High | -7.99% | -5.03% |
Valuation
| Metric | ADANIENT | SUNPHARMA |
|---|---|---|
| Market Cap | ₹4.03 L Cr | ₹4.65 L Cr |
| P/E Ratio | 51.69x | 38.39x |
| P/B Ratio | 4.76x | 5.56x |
| EPS | ₹57.49 | ₹50.4 |
| Book Value | ₹626.03 | ₹348 |
| Dividend Yield | 0.04% | 0.82% |
Growth
| Metric | ADANIENT | SUNPHARMA |
|---|---|---|
| Revenue Growth (TTM YoY) | 20.3% | 12.8% |
| EPS Growth (TTM YoY) | 0% | 25.6% |
| Qtr Sales Growth | 20.3% | 10.5% |
| Qtr Profit Growth | -121% | 5.95% |
Profitability & Leverage
| Metric | ADANIENT | SUNPHARMA |
|---|---|---|
| ROE | -3.38% | 16% |
| ROCE | 5.8% | 20.5% |
| Net Margin | 9.3% | 18.56% |
| Operating Margin | 13.9% | 29.8% |
| Debt to Equity | 1.32x | 0.06x |
Shareholding
As of Jul 2026 • change vs previous quarter| Metric | ADANIENT | SUNPHARMA |
|---|---|---|
| Promoter Holding | 57%▼ 2.27 pp | 54.48% |
| FII Holding | 10.52%▲ 1.75 pp | 14.53%▼ 1.4 pp |
| DII Holding | 10.75%▲ 1.42 pp | 22.18%▲ 1.07 pp |
| Public Holding | 6.77%▼ 0.28 pp | 8.81%▲ 0.33 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Adani Enterprises Ltd and Sun Pharmaceutical Industries Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.